TIAA Trust National Association increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 131,686 shares of the healthcare conglomerate's stock after buying an additional 7,796 shares during the period. TIAA Trust National Association's holdings in UnitedHealth Group were worth $66,615,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $40,000. Institutional investors and hedge funds own 87.86% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on UNH shares. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research note on Thursday, December 5th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Finally, Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Buy" and an average price target of $629.32.
Read Our Latest Research Report on UNH
UnitedHealth Group Stock Performance
Shares of UNH stock traded up $2.11 during midday trading on Friday, hitting $517.83. 1,193,911 shares of the company were exchanged, compared to its average volume of 4,262,706. The firm's 50 day moving average price is $508.70 and its two-hundred day moving average price is $545.16. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $473.66 billion, a P/E ratio of 33.38, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the company posted $5.83 EPS. The firm's quarterly revenue was up 6.8% on a year-over-year basis. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. UnitedHealth Group's dividend payout ratio is presently 54.19%.
Insider Activity at UnitedHealth Group
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.